undefined undefined
NaN.000
NaN.00%
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
05-10 13:52
An update from AbCellera Biologics (ABCL) is now available. On May 7, 2024, dur...
05-08 04:33
AbCellera (NASDAQ:ABCL) has inked an agreement with Viking Global Investors and ArrowMark Partners to develop new antibody drug programs, with an initial focus on immunology. The partnership also sees...
05-01 23:44
The European Union's drug regulator has delayed it decision on Eisai (OTCPK:ESALF) (OTCPK:ESAIY) and partner Biogen's (NASDAQ:BIIB) breakthrough Alzheimer's therapy, Leqembi (lecanemab). Lecanemab, a ...
03-22 20:50
AbCellera (NASDAQ:ABCL) and Biogen Inc. (NASDAQ:BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in
03-11 21:03
分析师Jan Hatzius和他的团队认为,肥胖者不太可能工作,工作效率也较低。因此,假设美国的肥胖率超过40%,他们对国家总产出的影响超过1%。
02-23 06:54
Benchmark analyst Robert Wasserman upgrades AbCellera Biologics (NASDAQ:ABCL) from Hold to Buy.
02-22 20:05
AbCellera Biologics (NASDAQ:ABCL) reported its Q4 earnings results on Tuesday, ...
02-21 05:30
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
02-20 19:52